We’re on the cusp of a gene editing revolution, are we ready?
By Editorial,
New Scientist
| 07. 27. 2016
THERE’S a certain breed of techno-optimist who likes to talk about “the singularity” – a time when technology progresses so rapidly that life is transformed beyond recognition. The driving force of this hypothetical event is artificial intelligence, but biotech plays a key role too.
...
But there are dangers ahead – not least the science outpacing public consent. Two teams in China have already tried to engineer human embryos. That seems unnecessarily hasty given the ethical issues it raises.
Those who work on CRISPR have a duty to consider not just the science but also how it will be received. As yet, CRISPR has hardly registered in public debate.
Image via Pixabay
Related Articles
By Ron Leuty, San Francisco Business Times | 06.16.2025
23andMe's two-step sale to a nonprofit led by former CEO Anne Wojcicki is nothing more than a dance around California's genetic privacy law, state Attorney General Rob Bonta said in a filing late Monday, one day before a judge will...
By Staff, The Associated Press | 06.10.2025
PORTLAND, Ore. — Twenty-seven states and the District of Columbia on Monday filed a lawsuit in bankruptcy court seeking to block the sale of personal genetic data by 23andMe without customer consent. The lawsuit comes as a biotechnology company seeks...
By Donald Earl Collins, Al Jazeera | 05.23.2025
“The picture of the world’s richest man killing the world’s poorest children is not a pretty one,” Microsoft founder and billionaire philanthropist Bill Gates said of Elon Musk during an interview with The Financial Times earlier this month. Gates indirectly...
By Katie Sagaser, The DNA Exchange | 05.27.2025
Disclaimer: The views and opinions expressed in this piece are solely my own and do not represent those of my employer, past or present, or any affiliated institutions. This content is provided for general informational purposes only and does not...